Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
ImmuneSense Lyme is a study, which is designed to better understand the immune response to Lyme disease. This is critically important because the immune system may be able to tell us important information about how our own bodies detect and respond to the disease that current tests cannot. De-identified data collected from this study may accelerate the development of better diagnostics for Lyme disease and improve outcomes for many.
Description: Diagnostic sensitivity is defined as the percentage of persons who have a given disorder who are identified by the assay as positive for Lyme disease.
Measure: To demonstrate Sensitivity of immunoSEQ Dx Lyme Assay is superior to STTT Time: BaselineDescription: Diagnostic specificity is defined as the percentage of persons who do not have a given condition who are identified by the assay as negative for Lyme disease.
Measure: To demonstrate Specificity of immunoSEQ Dx Lyme Assay is noninferior to STTT Time: BaselineDescription: To demonstrate ability of immunoSEQ Dx Lyme Assay to detect Lyme disease over the time at base line, 1 months, 6 months, and 12 months
Measure: To demonstrate ability of immunoSEQ Dx Lyme Assay to detect Lyme disease over the time Time: Base line, 30 days, 6 months, 12 months